Results 81 to 90 of about 21,166 (196)

Immunotherapeutic approaches for hepatocellular carcinoma [PDF]

, 2017
Hepatocellular carcinoma (HCC) is a cancer with a high mortality rate due to the fact that the diagnosis usually occurs at anadvanced stage. Even in case of curative surgical treatment, recurrence is common.
Aprile, G, Brunetti, O., Gardini, AC, Gnoni, A, Licchetta, A, Longo, V, Memeo, R, Nardulli, P, Palmieri, VO, Pisconti, S, Santini, D, SCARTOZZI, MARIO, Silvestris, N   +12 more
core   +2 more sources

Update in management of hepatocellular carcinoma in Eastern population [PDF]

, 2015
Hepatocellular carcinoma (HCC) is one of the commonest malignant tumours in the East. Although the management of HCC in the West is mainly based on the Barcelona Clinic for Liver Cancer staging, it is considered too conservative by Asian countries where ...
Cheung, TT, Chu, KK
core   +1 more source

Multi-modality curative treatment of salivary gland cancer liver metastases with drug-eluting bead chemoembolization, radiofrequency ablation, and surgical resection: a case report [PDF]

, 2011
Introduction Liver metastases are rare in salivary gland tumors and have been reported only once to be the first manifestation of the disease. They are usually treated with surgical resection of the primary tumor and systemic chemotherapy.
Andreas Karatzas, Konstantinos Katsanos, Ioannis Maroulis, Christina Kalogeropoulou, Evaggelos Tzorakoleftherakis, Dimitris Karnabatidis   +5 more
core   +2 more sources

Yttrium-90 radioembolization for advanced inoperable hepatocellular carcinoma [PDF]

, 2015
published_or_final_versio
Kwong, DLW, Law, MW, Lee, VHF, Leung, DKC, Leung, TW, Luk, MY, Ng, CY, Poon, RTP, Tong, CC, Wong, KK   +9 more
core   +1 more source

Outcome of transarterial chemoembolization in patients with inoperable hepatocellular carcinoma eligible for radiofrequency ablation [PDF]

, 2005
Aim: To evaluate the outcome of transarterial chemoembolization (TACE) in patients with unresectable hepatocellular carcinoma (HCC) 3 cm in diameter were adverse prognostic factors in multivariate analysis.
Fan, ST, Liem, MSL, Lo, CM, Poon, RTP, Tso, WK   +4 more
core   +1 more source

Predictive Factors for Complete Response and Recurrence after Transarterial Chemoembolization in Hepatocellular Carcinoma

Gut and Liver, 2017
Background/AimsTo investigate the predictive factors for complete response (CR) and recurrence after CR in patients with hepatocellular carcinoma (HCC) treated with transarterial chemoembolization (TACE).Methods : Among 691 newly diagnosed HCC patients ...
Shin Ok Jeong, Eui Bae Kim, Soung Won Jeong, Jae Young Jang, Sae Hwan Lee, Sang Gyune Kim, Sang Woo Cha, Young Seok Kim, Young Deok Cho, Hong Soo Kim, Boo Sung Kim, Yong Jae Kim, Dong Erk Goo, Su Yeon Park   +13 more
doaj   +1 more source

Double-contrast magnetic resonance imaging of hepatocellular carcinoma after transarterial chemoembolization [PDF]

, 2018
Background: The purpose of this study was to assess the accuracy of double-contrast magnetic resonance (MR) imaging for the treatment response evaluation of hepatocellular carcinoma (HCC) in cirrhotic liver after transarterial chemoembolization (TACE ...
Andreisek, Gustav, Bolog, Nicolae, Müllhaupt, Beat, Pfammatter, Thomas, Weishaupt, Dominik   +4 more
core  

Targeted therapy of advanced gallbladder cancer and cholangiocarcinoma with aggressive biology: eliciting early response signals from phase 1 trials. [PDF]

, 2013
PurposePatients with advanced cholangiocarcinoma (CC) and gallbladder carcinoma (GC) have few therapeutic options for relapsed disease. methods: Given the overall poor prognosis in this population and the availability of novel targeted therapies, we ...
Falchook, Gerald S, Fu, Siqing, Hess, Kenneth R, Hong, David S, Janku, Filip, Javle, Milind, Kaseb, Ahmed O, Kurzrock, Razelle, Naing, Aung, Piha-Paul, Sarina, Subbiah, Ishwaria M, Subbiah, Vivek, Tsimberidou, Apostolia M, Wheler, Jennifer J, Wolff, Robert A   +14 more
core   +2 more sources

Trans-arterial embolisation therapies for unresectable intrahepatic cholangiocarcinoma: A systematic review [PDF]

, 2015
Background: Unresectable intrahepatic cholangiocarcinoma (ICC) portends a poor prognosis despite standard systemic treatments which confer minimal survival benefits and significant adverse effects.
Bester, L, Morris, D, Saxena, A, Shan, J, Shan, L, Yang, L.   +5 more
core   +1 more source

Effectiveness and safety of transarterial chemoembolization combined with PD-1 inhibitors and lenvatinib for unresectable intrahepatic cholangiocarcinoma

European Radiology Experimental
Background The objective of this study was to evaluate the therapeutic effectiveness and safety of transarterial chemoembolization (TACE) combined with programmed cell death-1 (PD-1) inhibitors and lenvatinib in the treatment of unresectable intrahepatic
Jin-Tao Huang, Di Hu, Xin Hong, Wen-Jie Zhou, Jian Shen, Peng-Hua Lv, Xiao-Li Zhu   +6 more
doaj   +1 more source